A fusion ORF3a-E subgenomic RNA involved in SARS-CoV-2 infection efficacy by influencing cellular protein synthesis
Subgenomic RNAs (sgRNAs) are discontinuous transcription products of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that are involved in viral gene expression and replication, but their exact functions are still being studied. Here, we report the identification of a nested ORF3a-sgRNA, the fusion ORF3a-E-sgRNA, which is involved in the infection process of SARS-CoV-2. This sgRNA encodes both ORF3a and E and can be detected throughout the viral life cycle in SARS-CoV-2-infected cells with high copy numbers. ORF3a-E-sgmRNA guides ORF3a translation and promotes the expression of cellular ribosomal protein S3 (RPS3), increasing translation levels. Single-cell sequencing of a SARS-CoV-2-infected human bronchial epithelial cell line (16HBE) revealed that maintenance of this stable translational environment by ORF3a-E-sgmRNA is important for SARS-CoV-2 assembly and release capabilities and is also beneficial for viral evasion of host innate immunity. More importantly, the transcription level of ORF3a-E-sgRNA may contribute to differences in infection processes between the Wuhan strain and the XBB strain of SARS-CoV-2.
Authors
- Longding Liu (ORCID: https://orcid.org/0000-0002-1870-0035)
- Keqi Chen
- Xinglong Zhang (ORCID: https://orcid.org/0000-0003-1698-692X)
- Xin Zhao (ORCID: https://orcid.org/0000-0002-1078-7332)
- Xin Zhang (ORCID: https://orcid.org/0000-0002-5941-3921)
- Heng Li (ORCID: https://orcid.org/0000-0003-4874-2874)
- Yifan Zhang (ORCID: https://orcid.org/0000-0002-0283-0468)
- Zihan Zhang (ORCID: https://orcid.org/0000-0002-8099-5081)
- Jiali Li (ORCID: https://orcid.org/0000-0001-5111-740X)
- Jing Li (ORCID: https://orcid.org/0000-0003-3684-3491)
- Yingyan Li (ORCID: https://orcid.org/0000-0002-4815-2252)
- Haijing Shi
- Shasha Peng
Institutions
- Yunnan University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Kunming Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fimmu.2025.1619538
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China